FT Vest美國股票深度緩衝主動型ETF-3月 DMAR 深 滬
已收盤 05-08 16:00:00 美东时间
44.3353
+0.095
+0.22%
華盛通- 最 高44.38
- 今 開44.38
- 成交量 7251股
- 最 低 44.28
- 昨 收 44.2401
- 總市值 4.19亿
- 52周最高 44.38
- 市盈率 靜 --
- 換手率 0.08%
- 52周最低 38.32
- 委 比 -33.33%
- 總股本 945.00万
- 歷史最高 44.38
- 量 比 0.50
- 振 幅 0.23%
- 歷史最低 29.15
- 每 手 1
- 風險率 1.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Artiva Biotherapeutics Stock Slides Despite Positive Trial Data
Artiva Biotherapeutics shares fall after Phase 2a rheumatoid arthritis data and a $300 million private placement announcement.
05-09 00:20
Bristol Myers Squibb Says European Commission Grants Approval To Sotyktu, Alone Or In Combination With Methotrexate, For Treatment Of Active Psoriatic Arthritis In Adults
In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in quality of life as
05-08 19:00
BMS wins EU approval for Sotyktu to treat active psoriatic arthritis in adults
BMS wins EU approval for Sotyktu to treat active psoriatic arthritis in adults European Commission granted marketing authorization for Sotyktu (deucravacitinib) to treat active psoriatic arthritis in adults with inadequate response or intolerance to prior DMARD therapy. Label covers use as monothera
05-08 18:59
Avenue Supermarts Files Fiscal 2026 Investor Presentation with Stock Exchanges
Avenue Supermarts Ltd. ( ($IN:DMART) ) has issued an announcement. Avenue Super...
05-02 20:33
BRIEF-Landmark Bancorp Files Non-Timely 10-K With U.S. SEC
BRIEF-Landmark Bancorp Files Non-Timely 10-K With U.S. SEC April 1 (Reuters) - Landmark Bancorp Inc LARK.O : LANDMARK BANCORP INC FILES NON-TIMELY 10-K WITH U.S. SEC LANDMARK BANCORP - TO BEGIN INTERNAL PROBE WITH OUTSIDE COUNSEL INTO MISCONDUCT ALLEGATIONS INVOLVING NON-EXECUTIVE EMPLOYEE AT LANDMA
04-01 18:56
BRIEF-Coreweave Closes Landmark $8.5 Billion Financing Facility, Achieving First Investment-Grade Rated Gpu-Backed Financing
BRIEF-Coreweave Closes Landmark $8.5 Billion Financing Facility, Achieving First Investment-Grade Rated Gpu-Backed Financing March 31 (Reuters) - CoreWeave Inc CRWV.O : COREWEAVE CLOSES LANDMARK $8.5 BILLION FINANCING FACILITY, ACHIEVING FIRST INVESTMENT-GRADE RATED GPU-BACKED FINANCING Source text:
03-31 20:39
Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Fennec Pharmaceuticals (FENC) to release Q4 earnings on March 24. Analysts expect EPS of $0.04 and revenue of $14.73 million. Stock gained 1.8% on Monday.
03-24 04:40
Fennec Pharmaceuticals Settles PEDMARK Patent Litigation With Cipla; Blocking Generic Entry Until September 2033
Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the litigation between them
03-16 20:13
Fennec Pharmaceuticals settles PEDMARK patent litigation with Cipla, bars generic entry until Sept. 1, 2033
Fennec Pharmaceuticals settles PEDMARK patent litigation with Cipla, bars generic entry until Sept. 1, 2033 Fennec said it reached a settlement with Cipla to resolve litigation over Cipla’s FDA application to market a generic version of PEDMARK. Under the agreement, the lawsuit will be dismissed and
03-16 20:08
Avenue Supermarts Vests 1.51 Million ESOPs Under 2016 Scheme
Avenue Supermarts Ltd. ( ($IN:DMART) ) has provided an update. Avenue Supermart...
03-15 00:33
